AR047782A1 - SOLID PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A COMBINATION OF DROSPIRENONE, ETHYLYNESTRADIOL AND AN APPROPRIATE SURFACTING AGENT THAT PRESENTS A HOMOGENEITY OF CONTENT AND SPEED OF DISSOLVED INSURANCE FOR NON-MICRONIZED DRUG, PROCEDURE FOR PREPARATION OF USE - Google Patents
SOLID PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A COMBINATION OF DROSPIRENONE, ETHYLYNESTRADIOL AND AN APPROPRIATE SURFACTING AGENT THAT PRESENTS A HOMOGENEITY OF CONTENT AND SPEED OF DISSOLVED INSURANCE FOR NON-MICRONIZED DRUG, PROCEDURE FOR PREPARATION OF USEInfo
- Publication number
- AR047782A1 AR047782A1 ARP040104928A AR047782A1 AR 047782 A1 AR047782 A1 AR 047782A1 AR P040104928 A ARP040104928 A AR P040104928A AR 047782 A1 AR047782 A1 AR 047782A1
- Authority
- AR
- Argentina
- Prior art keywords
- drospirenone
- speed
- combination
- pharmaceutical composition
- ethylynestradiol
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente se relaciona con una composicion farmacéutica asegurando una velocidad de disolucion y homogenizacion de la droga no micronizada logrando una estabilidad físico-química inesperada. También con la composicion farmacéutica obtenida por ese proceso y el uso de la composicion farmacéutica para preparar un medicamento. La composicion farmacéutica comprende, una combinacion de dos principios activos, a saber drospirenona y etinilestradiol, un agente surfactante y excipientes farmacéuticamente aceptables con la condicion de que la drospirenona presente la siguiente distribucion: aproximadamente el 95 % de ellos presenten un tamano de partícula inferior a 100 (mu)m, aproximadamente el 26 % presente un tamano de partícula inferior a 20 (mu)m y aproximadamente el 15 % presente un tamano de partícula inferior a 1.000 (mu)m, o con la condicion de que dichos principios activos presenten un área superficial menor a 10.000 cm2/g o con la condicion que la drospirenona no se encuentra en forma micronizada. Esta composicion es usada para inhibir la ovulacion y los cambios en la secrecion cervical.This is related to a pharmaceutical composition ensuring a speed of dissolution and homogenization of the non-micronized drug achieving unexpected physical-chemical stability. Also with the pharmaceutical composition obtained by that process and the use of the pharmaceutical composition to prepare a medicine. The pharmaceutical composition comprises, a combination of two active ingredients, namely drospirenone and ethinyl estradiol, a pharmaceutically acceptable surfactant and excipients with the proviso that drospirenone has the following distribution: approximately 95% of them have a particle size less than 100 (mu) m, approximately 26% have a particle size of less than 20 (mu) m and approximately 15% have a particle size of less than 1,000 (mu) m, or with the proviso that said active ingredients have a surface area less than 10,000 cm2 / g or with the condition that drospirenone is not in micronized form. This composition is used to inhibit ovulation and changes in cervical secretion.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ARP040104928 AR047782A1 (en) | 2004-12-28 | 2004-12-28 | SOLID PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A COMBINATION OF DROSPIRENONE, ETHYLYNESTRADIOL AND AN APPROPRIATE SURFACTING AGENT THAT PRESENTS A HOMOGENEITY OF CONTENT AND SPEED OF DISSOLVED INSURANCE FOR NON-MICRONIZED DRUG, PROCEDURE FOR PREPARATION OF USE |
UY29227A UY29227A1 (en) | 2004-12-28 | 2005-11-24 | SOLID PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A COMBINATION OF DROSPIRENONE, ETHYNYLESTRADIOL AND AN APPROPRIATE SURFACTING AGENT THAT PRESENT A HOMOGENEITY OF CONTENT AND SPEED OF DISSOLUTION INSURED FOR NON-MICRONIZED DRUG |
CO05130115A CO5770093A1 (en) | 2004-12-28 | 2005-12-27 | SOLID PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A COMBINATION OF DROSPIRENONE, ETHYLINESTRADIOL AND AN APPROPRIATE SOUTHFACTING AGENT THAT PRESENTS A HOMOGENEITY OF CONTENT AND SPEED OF DISSOLVED INSURANCE FOR NON-MICRONIZED DRUG, RPOCEDI |
PE2006000018A PE20061112A1 (en) | 2004-12-28 | 2006-01-03 | PHARMACEUTICAL COMPOSITIONS INCLUDING DROSPIRENONE, ETHINYLESTRADIOL AND SURFACTING AGENT |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ARP040104928 AR047782A1 (en) | 2004-12-28 | 2004-12-28 | SOLID PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A COMBINATION OF DROSPIRENONE, ETHYLYNESTRADIOL AND AN APPROPRIATE SURFACTING AGENT THAT PRESENTS A HOMOGENEITY OF CONTENT AND SPEED OF DISSOLVED INSURANCE FOR NON-MICRONIZED DRUG, PROCEDURE FOR PREPARATION OF USE |
Publications (1)
Publication Number | Publication Date |
---|---|
AR047782A1 true AR047782A1 (en) | 2006-02-22 |
Family
ID=36607162
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP040104928 AR047782A1 (en) | 2004-12-28 | 2004-12-28 | SOLID PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A COMBINATION OF DROSPIRENONE, ETHYLYNESTRADIOL AND AN APPROPRIATE SURFACTING AGENT THAT PRESENTS A HOMOGENEITY OF CONTENT AND SPEED OF DISSOLVED INSURANCE FOR NON-MICRONIZED DRUG, PROCEDURE FOR PREPARATION OF USE |
Country Status (4)
Country | Link |
---|---|
AR (1) | AR047782A1 (en) |
CO (1) | CO5770093A1 (en) |
PE (1) | PE20061112A1 (en) |
UY (1) | UY29227A1 (en) |
-
2004
- 2004-12-28 AR ARP040104928 patent/AR047782A1/en unknown
-
2005
- 2005-11-24 UY UY29227A patent/UY29227A1/en not_active Application Discontinuation
- 2005-12-27 CO CO05130115A patent/CO5770093A1/en not_active Application Discontinuation
-
2006
- 2006-01-03 PE PE2006000018A patent/PE20061112A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CO5770093A1 (en) | 2007-06-29 |
PE20061112A1 (en) | 2006-11-27 |
UY29227A1 (en) | 2005-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6082249B2 (en) | Transdermal gel preparation | |
Moghissi | Medical treatment of endometriosis | |
US8647665B2 (en) | Methods of treating hot flashes with formulations for transdermal or transmucosal application | |
US20110245215A1 (en) | Transdermal delivery systems for active agents | |
ES2281551T3 (en) | METHOD OF PREVENTION OR TREATMENT OF BENIGN GYNECOLOGICAL DISEASES. | |
EP2246049A3 (en) | Pharmaceutical composition and dosage forms for administration of hydrophobic drugs | |
AR018410A1 (en) | USE OF A COMPOSITION FOR THE MANUFACTURE OF A MEDICINAL PRODUCT USED FOR THE PREVENTION OR TREATMENT OF AN ACUTE STATE OF ASTHMA AND / OR ASTHMA INTERMITENTEY / OR EPISODES OF CHRONIC ASTHMA AND METHOD FOR THE PREVENTION OR TREATMENT OF AN ACUTE STATE OF ASTHMA AND / OR INTERMITTENT ASTHMA AND / OR ASTHON CRON EPISODES | |
KR20060054320A (en) | Transdermal hormone delivery system: compositions and methods | |
MEP38008A (en) | Drospirenone for hormone replacement therapy | |
JP2009519958A (en) | Fluxable compositions and methods for skin delivery of drugs | |
CN106604717B (en) | Topical diclofenac sodium compositions | |
TW200514560A (en) | Pharmaceutical formulation for contraception and hormone-replacement therapy | |
KR970706001A (en) | PROCESS OF MAKING DOSAGE UNITS BY WET GRANULATION BY WET-GRANULATION | |
Pearson et al. | Antiestrogen treatment of breast cancer: an overview | |
WO2000007599A1 (en) | Prevention of endometriosis signs or symptoms | |
AR045719A1 (en) | PHARMACEUTICAL FORMULATION THAT INCLUDES SODIUM LEVOTIROXIN, MICROCRYSTALLINE CELLULOSE AND PREGELATINIZED ALMIDON; USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT AND PROCESS TO PREPARE THIS FORMULATION | |
AR036970A1 (en) | ANDROGENIC PHARMACEUTICAL COMPOSITION AND METHOD FOR THE TREATMENT OF DEPRESSION | |
AR047782A1 (en) | SOLID PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A COMBINATION OF DROSPIRENONE, ETHYLYNESTRADIOL AND AN APPROPRIATE SURFACTING AGENT THAT PRESENTS A HOMOGENEITY OF CONTENT AND SPEED OF DISSOLVED INSURANCE FOR NON-MICRONIZED DRUG, PROCEDURE FOR PREPARATION OF USE | |
AR045576A1 (en) | PHARMACEUTICAL COMPOSITION INCLUDING DROSPIRENONE AND ETHYLESTRADIOL | |
DOP2005000278A (en) | SOLID PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A COMBINATION OF DROSPIRENON, ETHYLINESTRADIOL AND A SUITABLE SURFACTANT AGENT THAT PRESENT A HOMOGENEITY OF CONTAINED SPEED AND SPEED OF DRUG FOR NON-MICRONIZED DRUG, PROCEDURE FOR PREPARATION FOR COMPOSITION PREPARATION. | |
Von Schoultz | Clinical efficacy and safety of combined estradiol valerate and dienogest: a new no-bleed treatment | |
RU2000115313A (en) | GESTAGEN-ANTI-GESTAGEN RECEPTION DIAGRAMS | |
PE20010665A1 (en) | A PHARMACEUTICAL COMPOSITION OF DROSPIRENONE AND ETHINYLESTRADIOL TO BE USED AS A CONTRACEPTIVE | |
Sitruk-Ware et al. | Patent: Nestorone®/estradiol transdermal gel | |
AR026747A1 (en) | EPERENONA CRYSTAL FORM |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |